| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/13/2000 | CN1266459A Method and reagents for vaccination which generate a CD8 T cell immune response |
| 09/13/2000 | CN1056382C Improved HCV diagnostic agents |
| 09/13/2000 | CN1056315C Poly I : C compound immunologic adjuvant and vaccine containing the adjuvant |
| 09/12/2000 | USRE36866 Anti-aids immunotoxins |
| 09/12/2000 | US6117982 Microbead coupled with binding molecules which lack fc portions and are specific for cd2, cd3 or other t cell receptor-linked components, cd4, cd5 or cd8; anticarcinogenic agents and treatment of infections |
| 09/12/2000 | US6117903 Extracts of Salvia species having antiviral activity |
| 09/12/2000 | US6117836 Glycosylation-mediated inhibition of factor X |
| 09/12/2000 | US6117667 Method for producing an adapted virus population from an African green monkey kidney cell line |
| 09/12/2000 | US6117662 Respiratory nitrate reductase alpha subunit |
| 09/12/2000 | US6117653 Hepatitis B surface antigen vaccine |
| 09/12/2000 | US6117645 Human LH-RH receptor expression cells and use thereof |
| 09/12/2000 | US6117640 Recombinant vaccine made in E. coli against dengue virus |
| 09/12/2000 | US6117449 A liposomal preparation comprising lyophilized liposomes containing at least one antigen selected from the group consisting of hepatitis b and hepatitis c antigens and mixtures, and liposomes have atleast three different sizes |
| 09/12/2000 | US6117445 Administration of an a1 adenosine receptor antagonist, or p2x purinoceptor or a compination of both offer potential as an antifibrotic or antisclerotic treatment |
| 09/12/2000 | US6117432 Aluminum acetate or salicylate adjuvant |
| 09/12/2000 | US6117427 Administering immunogenic protein-alkaloid conjugate having indolo(4,3-fg)quinoline derivative |
| 09/12/2000 | US6117426 Human amine transporter polypeptide fragments |
| 09/12/2000 | US6117423 Highly purified species of human leukocyte interferon |
| 09/12/2000 | US6117421 Method for promoting cell growth and immunosuppression using chaperonin |
| 09/12/2000 | CA2158024C A mycoplasma gallisepticum antigen, dna encoding the antigen, recombinant vector bearing the dna and recombinant virus utilizing the recombinant vector as well as use thereof |
| 09/12/2000 | CA2021762C Antigens and methods therefor |
| 09/11/2000 | CA2276066A1 Microparticles for delivery of nucleic acid |
| 09/08/2000 | WO2000052167A1 Angiopoietin-related protein and nucleic acids |
| 09/08/2000 | WO2000052165A2 Compositions and methods for breast cancer therapy and diagnosis |
| 09/08/2000 | WO2000052157A1 Tumor-associated antigen |
| 09/08/2000 | WO2000052147A2 Bacterial prolyl peptidases and methods of use |
| 09/08/2000 | WO2000052056A2 Anti-plasmodium compositions and methods of use |
| 09/08/2000 | WO2000052054A2 Antibodies for cancer therapy and diagnosis |
| 09/08/2000 | WO2000052053A1 Antibodies against phosphomannan that are protective against candidiasis |
| 09/08/2000 | WO2000052046A1 Immunomodulating glycopeptide |
| 09/08/2000 | WO2000052045A2 Mage-3 derived immunogenic peptides presented by mhc of class ii and the use thereof |
| 09/08/2000 | WO2000052044A1 Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof |
| 09/08/2000 | WO2000052041A1 Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis |
| 09/08/2000 | WO2000052040A1 Hiv peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by hiv |
| 09/08/2000 | WO2000052028A1 TUMOR NECROSIS FACTOR RECEPTORS 6α and 6$g(b) |
| 09/08/2000 | WO2000052022A1 Secreted proteins and nucleic acids encoding them |
| 09/08/2000 | WO2000051647A2 Animal model of allergies |
| 09/08/2000 | WO2000051635A2 Emulsan and emulsan analogs immunization formulations and use |
| 09/08/2000 | WO2000051634A1 Vaccine preparations containing fatty acids as constituent |
| 09/08/2000 | WO2000051633A2 MULTI-COMPONENT VACCINE COMPRISING AT LEAST THREE ANTIGENS TO PROTECT AGAINST DISEASE CAUSED BY $i(HAEMOPHILUS INFLUENZAE) |
| 09/08/2000 | WO2000051632A2 COPPER AGONIST THAT BINDS ON THE COPPER BINDING SITE OF APP AND/OR EXERTS AN INHIBITING EFFECT ON THE RELEASE OF AMYLOID Aβ PEPTIDE |
| 09/08/2000 | WO2000051630A2 Methods for improving graft acceptance in a recipient by administration of a cytokine profile altering agent |
| 09/08/2000 | WO2000051432A1 Vaccines and gene therapy compositions and methods of making and using the same |
| 09/08/2000 | WO2000029583A3 Immunoglobulin superfamily proteins |
| 09/08/2000 | WO2000027414A3 Inhibition of the formation of vascular hyperpermeability |
| 09/08/2000 | WO2000023592B1 Minimal promoters and uses thereof |
| 09/08/2000 | WO2000019206A9 Ykl-40 as a marker and prognostic indicator for cancers |
| 09/08/2000 | WO2000015853A9 Recombinant newcastle disease virus rna expression systems and vaccines |
| 09/08/2000 | WO2000013702A3 Use of an angiogenic factor for the treatment of microvascular angiopathies |
| 09/08/2000 | WO2000012497B1 Quinazoline derivatives as medicaments |
| 09/08/2000 | WO2000004921A9 Avian leukosis virus subgroup j envelope gene product for diagnosis and vaccine |
| 09/08/2000 | WO1999064595A9 THERAPEUTIC AND DIAGNOSTIC DOMAIN 1 β2GPI POLYPEPTIDES AND METHODS OF USING SAME |
| 09/08/2000 | CA2371934A1 Copper agonist that binds on the copper binding site of app and/or exerts and inhibiting effect on the release of amyloid a.beta. peptide |
| 09/08/2000 | CA2368539A1 Tumor-associated antigen |
| 09/08/2000 | CA2364279A1 Methods for improving graft acceptance in a recipient by administration of a cytokine profile altering agent |
| 09/08/2000 | CA2364002A1 Mage-3 derived immunogenic peptides presented by mhc of class ii and the use thereof |
| 09/08/2000 | CA2363957A1 Immunomodulating glycopeptide |
| 09/08/2000 | CA2362924A1 Secreted proteins and nucleic acids encoding them |
| 09/08/2000 | CA2362873A1 Vaccines and gene therapy compositions and methods of making and using the same |
| 09/08/2000 | CA2362840A1 Antibodies against phosphomannan that are protective against candidiasis |
| 09/08/2000 | CA2362547A1 Angiopoietin-related protein and nucleic acids |
| 09/08/2000 | CA2362477A1 Anti-plasmodium compositions and methods of use |
| 09/08/2000 | CA2361877A1 Antibodies for cancer therapy and diagnosis |
| 09/07/2000 | DE19912706A1 New staphylococcal DNA for dltABCD operons, useful e.g. for identifying antibacterials and agents that reduce bacterial resistance to antimicrobials |
| 09/07/2000 | DE19909503A1 Tumorassoziiertes Antigen Tumor-associated antigen |
| 09/07/2000 | DE19909357A1 Kupferagonist, der an die Kupferbindungsstelle von APP bindet und/oder eine hemmende Wirkung auf die Freisetzung des Amyloid-Aß-Peptids ausübt Kupferagonist which binds to the copper binding site of APP and / or exerts an inhibitory effect on the release of the amyloid Aß-peptide |
| 09/07/2000 | DE19860438C1 Verfahren zur Herstellung von Autovakzinen zur Behandlung von Chlamydiosen von Säugetieren und Menschen A process for the production of vaccines for the treatment of auto chlamydioses of mammals and humans |
| 09/06/2000 | EP1033136A1 The process of preparing immunoglobulin for intravenous injection by viruses double-sterilized without adding any protectant |
| 09/06/2000 | EP1033135A1 Broadly reactive opsonic antibodies that react with common staphyloccoccal antigens |
| 09/06/2000 | EP1032706A1 Reagents and methods useful for detecting diseases of the breast |
| 09/06/2000 | EP1032696A1 Vector for tissue-specific replication and gene expression |
| 09/06/2000 | EP1032676A2 $i(CHLAMYDIA TRACHOMATIS) GENOMIC SEQUENCE AND POLYPEPTIDES, FRAGMENTS THEREOF AND USES THEREOF, IN PARTICULAR FOR THE DIAGNOSIS, PREVENTION AND TREATMENT OF INFECTION |
| 09/06/2000 | EP1032675A1 Attaching substances to micro-organisms |
| 09/06/2000 | EP1032674A2 $i(CHLAMYDIA PNEUMONIAE) GENOMIC SEQUENCE AND POLYPEPTIDES, FRAGMENTS THEREOF AND USES THEREOF, IN PARTICULAR FOR THE DIAGNOSIS, PREVENTION AND TREATMENT OF INFECTION |
| 09/06/2000 | EP1032670A1 Toso |
| 09/06/2000 | EP1032669A2 Recombinant allergen with reduced enzymatic activity |
| 09/06/2000 | EP1032667A2 A33-related antigens and their pharmacological uses |
| 09/06/2000 | EP1032665A1 A human 2-19 protein homologue, z219c |
| 09/06/2000 | EP1032662A1 Methods and compositions for immunomodulation |
| 09/06/2000 | EP1032660A1 Method of identifying binding site domains that retain the capacity of binding to an epitop |
| 09/06/2000 | EP1032653A1 Serum-free, low-protein media for rotavirus vaccine production |
| 09/06/2000 | EP1032650A1 Novel tig |
| 09/06/2000 | EP1032649A1 deoD |
| 09/06/2000 | EP1032595A2 Nucleic acids involved in the responder phenotype and applications thereof |
| 09/06/2000 | EP1032591A1 NOVEL pth |
| 09/06/2000 | EP1032583A1 Active immunization against angiogenesis-associated antigens |
| 09/06/2000 | EP1032582A1 NOVEL recJ |
| 09/06/2000 | EP1032426A1 Therapeutic agents |
| 09/06/2000 | EP1032423A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof |
| 09/06/2000 | EP1032422A1 Linear antigen supporting units |
| 09/06/2000 | EP1032421A1 Monoclonal human natural antibodies |
| 09/06/2000 | EP1032420A1 Immunoglobulin molecules having a synthetic variable region and modified specificity |
| 09/06/2000 | EP1032419A1 Saponin adjuvant composition |
| 09/06/2000 | EP1032418A1 Compact epstein-barr virus replicons |
| 09/06/2000 | EP1032417A1 Bacterial vaccines comprising auxotrophic, attenuated strains of listeria expressing heterologous antigens |
| 09/06/2000 | EP1032416A1 Neospora vaccines |
| 09/06/2000 | EP1032409A1 Herbal extract composition and method with immune-boosting capability |
| 09/06/2000 | EP1032269A1 Treatment of neoplasms with viruses |
| 09/06/2000 | EP0770089B1 Growth differentiation factor-12 |
| 09/06/2000 | EP0631502B1 Lymphocyte activity regulation by hla peptides |